The Human Frontier Science Program (HFSP) promotes international collaboration in basic research focused on the elucidation of the sophisticated and complex mechanisms of living organisms. HFSP suppor...
Federal spending by Canadian Institutes of Health Research
44,760 records totalling $16,856,641,799.63 CAD, from official Government of Canada open data.
Embed this chart
Where the money flows
Contracting
$107.3M
across 1,596 contracts over $10k
24.0%
of contract dollars awarded without competition (637 contracts)
79.2%
of contracts with known bid counts received one bid or fewer (432 reported)
"Without competition" counts solicitation codes TN (non-competitive) and AC (Advance Contract Award Notice). Non-competitive awards are legal and sometimes required; the rate is context, not a judgment.
Planned vs. actual spending
What Parliament authorised this organization to spend versus what it actually spent, across all its votes. Source: Public Accounts of Canada (via GC InfoBase). This covers the organization's entire budget, not just the grants and contracts listed below.
| Fiscal year | Authorised | Spent | Used |
|---|---|---|---|
| 2024-2025 | $1,425,650,302 | $1,424,372,236 | 99.9% |
| 2023-2024 | $1,376,632,495 | $1,348,456,197 | 98.0% |
| 2022-2023 | $1,362,336,995 | $1,336,911,908 | 98.1% |
| 2021-2022 | $1,392,863,725 | $1,384,299,264 | 99.4% |
| 2020-2021 | $1,619,428,462 | $1,503,461,560 | 92.8% |
| 2019-2020 | $1,205,650,152 | $1,202,050,854 | 99.7% |
| 2018-2019 | $1,158,962,199 | $1,150,927,127 | 99.3% |
| 2017-2018 | $1,098,368,793 | $1,097,161,184 | 99.9% |
| 2016-2017 | $1,083,194,536 | $1,081,330,344 | 99.8% |
| 2015-2016 | $1,029,250,394 | $1,026,378,153 | 99.7% |
Did it deliver? (2024-2025 results report)
Every department sets measurable performance targets and reports against them. Source: Departmental Results Reports via GC InfoBase — the department's own self-reported scorecard.
16
of 17 targets met
1
targets not met
0
not yet measurable or unavailable
See missed targets
-
Number of research projects funded jointly by CIHR and (an) international partner(s)
Target: — · Actual: 46.0
The Networks of Centres of Excellence (NCE) is a federal government initiative which funds partnerships between universities, industry, government and not-for-profit organizations to create large-scal...
SUPPORT Units will develop jurisdictional centres of expertise to enhance patient-oriented research and facilitate studies involving patients and/or patient records. SUPPORT Units are intended to: • I...
The Institute Support Grant is provided to the host institution at which the Institute’s Scientific Director is affiliated to sustain the Institute’s strategic development or Institute-led initiatives...
The objective is to facilitate the SDs continued participation as an active researcher.
The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...
Immune Regulation during Chronic Disease
Regulation of postsynaptic expression and function of ionotropic neurotransmitter receptors
Enhanced CARE for RARE Genetic Diseases in Canada
Innovative chemogenomic tools to improve outcome in acute myeloid leukemia
Personalized medicine in the treatment of epilepsy
Personalised Risk Stratification for Prevention and Early Detection of Breast Cancer
AUTISM SPECTRUM DISORDERS: GENOME to OUTCOMES
Personalized Treatment of Lymphoid Cancer: British Columbia as Model Province
UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
The Institute Support Grant for the CIHR Institute of Infection and Immunity (III), a constituent Institute of the Canadian Institutes of Health Research
The specific objectives of this funding opportunity are to: • Advance research to support more accurate data interpretation, diagnosis, and innovative solutions across healthcare through global coope...
Personalized Cancer Immunotherapy
PEGASUS: PErsonalized Genomics for prenatal Aneuploidy Screening USing maternal blood
The Reach Network
The specific objective of this funding opportunity are to: - provide the base/infrastructure funding to the CRISM Phase II Regional Nodes that will allow research teams to organize and collaborat...
IBD Genomic Medicine Consortium (iGenoMed): translating genetic discoveries into a personalized approach to treating the inflammatory bowel diseases
Genetic & Biological Studies of Brain Disorders
Functional Protein Dynamics in Health and Disease
The goal of this funding opportunity is to deliver a national training initiative focused on building capacity among Canadian researchers to engage in high quality, impactful research on how to design...